nanoPASS Hosts Webinar on Advanced Methodologies for Regulatory Testing of Nanomaterials

NIA Staff
3 min read

Summary

  • A landmark milestone was reached with the first ever nanomaterial-relevant Adverse Outcome Pathway receiving endorsement, signalling growing regulatory acceptance of animal-free safety assessment tools.

  • The webinar made the case that AOPs can bridge the gap between molecular-level chemical interactions and real-world health outcomes, giving regulators a credible framework for accepting New Approach Methodologies.

15 May 2024-  In a significant move to advance the safety and regulatory testing of chemicals and materials, the nanoPASS project hosted an impactful webinar titled "AOPs: A Tool to Include NAMs into Regulatory Testing" on April 11, 2024. This session highlighted the shift away from traditional animal testing towards adopting New Approach Methodologies (NAMs) within regulatory frameworks.

The webinar provided a deep dive into Adverse Outcome Pathways (AOPs), a promising tool that links molecular-level effects of chemicals directly to adverse health outcomes, facilitating the inclusion of NAMs in regulatory assessments. Experts from various fields shared insights on how AOPs are developed and established, particularly through the processes endorsed by international bodies like the OECD.

More News

Commission releases revised nanomaterial definition

The EU has published its updated nanomaterial definition, replacing the original 2011 text after a multi-year review process involving three JRC studies and a formal stakeholder consultation.Key changes address longstanding ambiguities around particle size boundaries, the particle number concentration threshold, and the treatment of materials like graphene and carbon nanotubes.A guidance document to support implementation is due before year end, and NIA members can access a dedicated factsheet breaking down what has changed and what it means in practice.

Read More

The assessment of the environmental behaviour of the registered zinc oxide nanoforms concluded by Germany

German regulators have concluded that zinc oxide nanoforms carry the same aquatic toxicity classification as other zinc compounds, but stopped short of ruling out particle-specific effects that could add to their overall hazard profile.The finding that toxicity varied between individual nanoforms points to the complexity of treating nanoforms as a single regulatory category, a question with broad implications for how nanomaterials are classified across the EU.

Read More

ECHA Highlights Regulatory Challenges and Research Needs for Nanomaterials

ECHA is sounding the alarm over critical gaps in analytical methods for nanomaterials, warning that without urgent action the foundations of chemical safety regulation could be undermined.The agency is pressing for faster completion of OECD test method revisions under the Malta Initiative, flagging the work as overdue and essential to keeping regulation functional.Key unresolved areas include toxicokinetic characterisation, biodegradation, bioaccumulation, and long-term effects on soils and sediments, alongside the validation of new approach methodologies for regulatory acceptance.

Read More